EXPRESS SCRIPTS, INC. for EXPRESS SCRIPTS, INC.
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
Issues related to Section 700 (Champus provisions) of the annual National Defense Authorization Act of 2012
| Lobbyist | Covered position, as disclosed |
|---|---|
| NANCY GILBRIDE | — |
| JONAH C HOUTS | — |
| MARY M ROSADO | — |
Labor Issues/Antitrust/Workplace LBR
Legislation to exempt certain pharmacies from the antitrust laws for puposes of negotiating with payers (HR 1409, HR 1946, HR 1839)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONAH C HOUTS | — |
| ROBERT W LIVELY | — |
| MARY M ROSADO | — |
Health Issues HCR
Regulatory policies related to health reform legislation: structure, drug benefits, disclosure Regulatory implementation of HITECH/Accounting of Disclosures FDA issues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONAH C HOUTS | — |
| ROBERT W LIVELY | — |
| MARY M ROSADO | — |
Medicare/Medicaid MMM
Health reform proposals that impact Medicare Part D such as formulary requirements, PBM disclosure provisions, closing of the Part D coverage gap. General regulatory changes and legislative issues that impact the Part D program such as direct negotiation (HR 2190, HR 2248, S 1206) & MTM expansion (HR 891/S 274). Statutory implementation of changes to the definition of AMP in Medicaid. Exclusion of specialty distributors' prompt pay discounts from the definition of Average Sales Price (HR 905/S 733).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONAH C HOUTS | — |
| ROBERT W LIVELY | — |
| MARY M ROSADO | — |
Pharmacy PHA
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 979); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (essential health benefits, grandfathering, value-base insurance design, Rx quality, electronic prescribing, PBM disclosure requirements, medical loss ratio); legislation to promote generic drugs (S. 27); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; Implementation of Zadroga Health Care Act; Legislation placing restrictions on pharmacy benefit design (HR 1971, S 1058)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONAH C HOUTS | — |
| ROBERT W LIVELY | — |
| MARY M ROSADO | — |
Taxation/Internal Revenue Code TAX
HR 4, Comprehensive 1099 Taxpayer Protection and Repayment of Exchange Subsidy Overpayments Act of 2011 Regulatory implementation of various tax provisions in the health reform legislation Repeal of the 3% tax withholding requirement for federal contractors
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONAH C HOUTS | — |
| ROBERT W LIVELY | — |
| MARY M ROSADO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.